News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PAREXEL International (PRXL) Forms Company Dedicated to China-Specific Approvals



9/30/2013 1:17:28 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

September 30, 2013 -- Parexel, the US clinical-stage CRO, has formed Ding Hui China Trials Solution, a Beijing company that is dedicated entirely to conducting trials that will gain product approvals in China. The rest of Parexel’s China offices participate in global clinical trials as well as China-specific tests. More details....

Stock Symbol: (NSDQ: PRXL)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES